Biotechnology Assets, S.A. (BST:041)
0.3600
+0.0210 (6.19%)
At close: Jul 3, 2025
Biotechnology Assets Revenue
In the year 2024, Biotechnology Assets had annual revenue of 2.97M EUR, down -24.13%. Biotechnology Assets had revenue of 1.86M in the half year ending December 31, 2024, with 3.34% growth.
Revenue
2.97M
Revenue Growth
-24.13%
P/S Ratio
9.36
Revenue / Employee
87.21K
Employees
34
Market Cap
27.76M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.97M | -943.29K | -24.13% |
Dec 31, 2023 | 3.91M | 950.58K | 32.14% |
Dec 31, 2022 | 2.96M | -324.07K | -9.87% |
Dec 31, 2021 | 3.28M | 390.31K | 13.50% |
Dec 31, 2020 | 2.89M | -345.59K | -10.68% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SAP SE | 35.15B |
Siemens Aktiengesellschaft | 77.82B |
Deutsche Telekom AG | 120.25B |
Allianz SE | 109.03B |
Rheinmetall AG | 10.48B |
Siemens Energy AG | 37.44B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 61.84B |
Siemens Healthineers AG | 23.14B |